Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
Conditions: Acute Respiratory Distress Syndrome; Sepsis Interventions: Drug: Inhaled Carbon Monoxide at CFK equation-determined personalized dose (200-500 ppm to achieve a COHb level of 6-8%); Other: Inhaled Medical air Sponsors: Brigham and Women's Hospital; Weill Medical College of Cornell University; Massachusetts General Hospital; Duke University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials